Neuberg Diagnostics has secured a USD 110 million investment from Kotak Alternate Asset Managers, marking the largest primary fund-raise in India's diagnostics sector.

Target Information

Neuberg Diagnostics, established in 2017 and headquartered in Chennai, has swiftly positioned itself as the fastest-growing and largest integrated diagnostics provider in India. The company ranks among the top four diagnostics firms of Indian origin and boasts an extensive network of over 10,000 touch points and more than 250 laboratories across 250 cities. Neuberg is dedicated to transforming the healthcare landscape in India, employing a highly skilled team that includes clinical pathologists, oncopathologists, biochemists, geneticists, and certified lab professionals capable of conducting over 5,000 types of tests.

As a leading player in the genomics sector, Neuberg Diagnostics excels in key areas such as newborn screening and reproductive genomics testing. Notably, it is the first of its kind in India to establish dedicated centers of excellence across various modalities, including genomics, proteomics, metabolomics, transplantation immunology, haemato-oncology, and histopathology.

Industry Overview in India

The diagnostics industry in India is currently experiencing significant growth, driven by increasing healthcare awareness, a rising prevalence of chronic diseases, and the demand for efficient and reliable diagnostic s